Targacept, Falk Pharma ulcerative colitis deal

Targacept (Winston-Salem, N.C.) and Dr. Falk Pharma (Freiburg, Germany) will develop Targacept's neuronal nicotinic receptor agonists to treat ulcerative colitis. Falk will have distribution rights to...